An interventional study of Tissue Doppler imaging and Conventional Echocardiography in Nephrotic Syndrome, sponsored by Sohag University. Recruiting at 1 site in Egypt. Open to participants aged 2 Years to 14 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-10-02.
Sponsored by Sohag University · Not applicable, Interventional, and Screening
Among 10 studies in Nephrotic Syndrome with a site in Egypt — 5 open to participants now, 6 under way, 1 of them phase 3. Nephrotic Syndrome · Egypt.
Among the 10 studies in Nephrotic Syndrome with a site in Egypt, this one is one of 3 that started in 2024, is one of 3 with no phase, and was the 7th registered.
191 studies on the registry are indexed under Nephrotic Syndrome; 65 are open to participants now.
Browse Nephrotic Syndrome studies →5 of the 10 studies in Nephrotic Syndrome with a site in Egypt are open now. Recruiting first, the newest first:
Mansoura University · Sites in Egypt
Ain Shams University · Sites in Egypt
Mansoura University · Sites in Egypt
Alexandria University · Sites in Egypt
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 50 Nephrotic Syndrome studies recruiting now, 23 (46%) set no upper age limit and 22 (44%) stop at 75 or younger; 37 take children under 18; 4 take healthy volunteers.
This study: 2 Years to 14 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 2022; this study’s year is marked. 3 started in 2024.
This study's planned enrollment of 60 is above the median of 46 across 122 interventional studies indexed under Nephrotic Syndrome.
Median enrollment 60 across the 7 interventional studies, 50 across the 3 observational. Of the 3 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 10 has an industry lead sponsor. The 5 most frequent:
Sohag University is the lead sponsor of 1,230 studies on the registry; 636 are open to participants now.
Sohag University has 3 studies filed under Nephrotic Syndrome — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 10 studies in Nephrotic Syndrome with a site in Egypt, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
nephrotic syndrome (NS) is one of the most common pediatric kidney diseases There is an increased incidence of heart disease in patients with primary nephrotic syndrome (PNS) compared to the normal population Conventional Echocardiography is usually utilized to diagnose myocardial dysfunction. Tissue Doppler imaging is a non-invasive cardiac imaging technique which measures the velocity of the longitudinal motion of the mitral annulus, tricuspid annulus and the basal part of interventricular septum
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Children with primary nephrotic syndrome.
Exclusion Criteria:
Patients who refuse to give written to study
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
steroid dependent nephrotic syndrome
Device: Tissue Doppler imaging and Conventional Echocardiography
steroid resistant nephrotic syndrome
Device: Tissue Doppler imaging and Conventional Echocardiography
non-invasive cardiac imaging technique which measures the velocity of the longitudinal motion of the mitral annulus, tricuspid annulus and the basal part of interventricular septum
Also known as: Conventional Echocardiography
cardiac performance evaluation in children with steroid dependent vs steroid resistant nephrotic syndrome
compairing of myocardial performance index (MPI)(Tei index) in nephrotic dependant and resistant nephrotic syndrom by calculating ejection time (ET) of right and left ventricle and mitral closure time (MCT) using tissue doppler
Time frame: 12 months
Plan to share: Undecided
Started Jul 2024 (actual). Primary completion is estimated for Jul 2025, 12 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.